Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Mallinckrodt
Boehringer Ingelheim
Cantor Fitzgerald
Accenture
US Department of Justice
Merck
US Army

Generated: May 25, 2018

DrugPatentWatch Database Preview

DIMETANE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Dimetane patents expire, and what generic alternatives are available?

Dimetane is a drug marketed by Wyeth Cons, Robins Ah, and Wyeth Ayerst. and is included in three NDAs.

The generic ingredient in DIMETANE is brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride. There are twenty-one drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride profile page.
Summary for DIMETANE
Drug patent expirations by year for DIMETANE
Synonyms for DIMETANE
( inverted question mark)-Brompheniramine maleate
(-)-2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate
(?)-Brompheniramine
(?)-Brompheniramine maleate
(+-)-2-p-Bromo-alpha-2-(dimethylamino)ethylbenzylpyridine maleate (1:1)
(+)-2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate
(+)-2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate (1:1)
(+/-)-Brompheniramine maleate
(+/-)-Brompheniramine maleate salt
(A+/-)-Brompheniramine maleate
(S)-2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridinium (Z)-maleate (1:1)
(y)-Brompheniramine maleate
[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine
[3-(4-Bromophenyl)-3-(2-pyridyl)propyl]dimethylamine
[3-(4-bromophenyl)-3-(pyridin-2-yl)propyl]dimethylamine
1-(N,N-Dimethylamino)-3-(p-bromophenyl)-3-(alpha-pyridyl)propane maleate
1-(p-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane
1-(p-bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane maleate
1-p-Bromophenyl-1-(2-pyridyl)-3-dimethylaminopropane maleate
156428-33-0
2- p-Bromo-a-2-(dimethylamino)ethylbenzylpyridine maleate
2-(p-Bromo-a-(2-dimethylamino)ethyl)benzyl)pyridine maleate
2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)-pyridinmaleate(1:1)
2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate
2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate (1:1)
2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridinemaleate(1:1)
2-(p-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine
2-(p-bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine maleate
2-[p-Bromo-.alpha.-[2-(dimethylamino)ethyl]benzyl]pyridine
2-Pyridinepropanamine, .gamma.-(4-bromophenyl)-N,N-dimethyl-
2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-
2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (+-)-, (Z)-2-butenedioate (1:1)
2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (+-)-, (Z)-butenedioate (1:1)
2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (2Z)-2-butenedioate (1:1)
2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (S)-, (Z)-2-butenedioate (1:1)
2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (Z)-butenedioate (1:1)
3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine
3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine maleate
3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine
3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine; maleic acid
3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine
3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine (2Z)-but-2-enedioate
3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-yl-propan-1-amine
3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine
3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine; (Z)-but-2-enedioic acid
3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine;(Z)-but-2-enedioic acid
3-(p-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine
3-(p-bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine maleate
32188-07-1
32865-01-3
8055-73-0
86-22-6
86-22-6 (Parent)
980-71-2
980-71-2 (maleate (1:1))
A6B359
AB00053703
AB00053703_19
AB00053703_20
AB0015066
AB2000679
AC-1311
AC-15955
AC1L1NEM
AC1NQXZ5
AK390907
AKOS005711313
AKOS015855858
Allent
Allent (Salt/Mix)
AN-15069
AN-42337
Antihistamine compound
API0001770
API0009139
AS-14101
AS-14674
B 2390
BC214875
BCP0726000240
BCP9000453
BCPP000315
BDBM50017666
Bioompheniramine hydrogen maleate
BPBio1_000672
BRD-A68723818-050-05-1
Bromfed
Bromfenex
Bromfeniramina
Bromfeniramina [INN-Spanish]
Bromopheniramine
Bromopheniramine maleate
bromphen
Brompheniramin
BROMPHENIRAMINE
Brompheniramine (INN)
Brompheniramine (maleate)
Brompheniramine [INN:BAN]
Brompheniramine d-form maleate
Brompheniramine fumarate
Brompheniramine hydrogen maleate
Brompheniramine maleate
Brompheniramine Maleate (1:1)
Brompheniramine maleate (USAN)
Brompheniramine maleate [USP]
Brompheniramine Maleate 1.0 mg/ml in Methanol (as free base)
Brompheniramine Maleate, Pharmaceutical Secondary Standard; Certified Reference Material
Brompheniramine maleate, United States Pharmacopeia (USP) Reference Standard
brompheniramine; butenedioic acid
brompheniramine; maleic acid
Brompheniraminehydrogenmaleate
Brompheniraminum
Brompheniraminum [INN-Latin]
Brotane
Brotane (TN)
BSPBio_000610
BSPBio_002641
C-19601
C06857
C20H23BrN2O4
CCG-204296
CCG-39068
CHEBI:3183
CHEBI:3184
CHEMBL1200961
CHEMBL811
CS-2595
CTK8F8346
d-Brompheniramine maleate
D00663
D07543
D08VXO
DB00835
Dexbrompheniramine Brompheniramine
Dexbrompheniramine maleate salt
Dimegan
Dimetane (Salt/Mix)
Dimetane (TN)
Dimetane Extentabs
Dimetane-ten
dimetanemaleate
Dimetapp Allergy
Dimotane
DivK1c_006846
DR001404
Drauxin
Drauxin (Salt/Mix)
Drixoral Syrup
DTXSID2052657
DTXSID5022691
Ebalin
EINECS 201-657-8
EINECS 213-562-9
EINECS 219-236-2
EU-0100201
FT-0603299
g-(4-bromophenyl)-n,n-dimethyl-2-pyridinepropanaminemaleate
gamma-(4-bromophenyl)-n,n-dimethyl-2-pyridinepropanamin(z)-2-butenedioate
gamma-(4-Bromophenyl)-N,N-dimethyl-2-pyridinepropanamine
Gammistin
GTPL7133
HE009978
HE398279
HMS1569O12
HMS1922O16
HMS2093O07
HMS2096O12
HMS2230I21
HMS2234D14
HMS3260J03
HMS3604F03
HSDB 3017
HY-B0480
Ilvin
KBio1_001790
KBio2_002162
KBio2_004730
KBio2_007298
KBio3_001861
KBioGR_001554
KBioSS_002162
l-Brompheniramine maleate
L001031
Lodrane
Lopac0_000201
LP00201
LS-130306
LS-130307
LS-130308
LS-130309
LS-130310
LS-177900
LS-187224
M126
MFCD00865691
MLS000028423
MLS001148196
MolPort-003-666-520
MolPort-005-935-546
MolPort-023-220-382
Nagemid
NCGC00015146-04
NCGC00015146-05
NCGC00015146-07
NCGC00015146-08
NCGC00089782-02
NCGC00093676-01
NCGC00093676-02
NCGC00093676-03
NCGC00093676-04
NCGC00093676-05
NCGC00260886-01
NSC-758652
NSC758652
Opera_ID_399
Oprea1_690847
p-Bromdylamine
para-Bromdylamine
Parabromdylamine
Parabromdylamine maleate
Parabromodylamine
Parabromodylamine maleate
PDSP1_000146
PDSP2_000145
Pharmakon1600-01503985
Prestwick_913
Prestwick0_000475
Prestwick1_000475
Prestwick2_000475
Prestwick3_000475
Pyridine, 2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)-
Pyridine, 2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)-, maleate (1:1)
Pyridine, 2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)-, maleate (1:1), (-)-
Pyridine, 2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)-, maleate (1:1), (S)-
Pyridine, 2-[p-bromo-.alpha.-[2-(dimethylamino)ethyl]benzyl]-
Rolabromophen
s2585
SBI-0050189.P003
SCHEMBL41913
SCHEMBL4814
SMR000058417
SMR000653459
SPBio_001619
SPBio_002549
SpecPlus_000750
Spectrum_001682
SPECTRUM1503985
Spectrum2_001610
Spectrum3_000981
Spectrum4_001107
Spectrum5_001537
Spentane
SR-01000003057
SR-01000003057-8
STL058559
Tox21_500201
Veltane
W-100095
ZDIGNSYAACHWNL-UHFFFAOYSA-N

US Patents and Regulatory Information for DIMETANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Cons DIMETANE brompheniramine maleate TABLET, EXTENDED RELEASE;ORAL 010799-010 Jun 10, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Robins Ah DIMETANE-DX brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride SYRUP;ORAL 019279-001 Aug 24, 1984 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Cons DIMETANE brompheniramine maleate TABLET, EXTENDED RELEASE;ORAL 010799-011 Jun 10, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Cons DIMETANE brompheniramine maleate TABLET;ORAL 010799-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Daiichi Sankyo
Federal Trade Commission
Colorcon
Cantor Fitzgerald
Covington
McKesson
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.